References
- Davies J. L., Kawaguchi Y., Bennett S., Copeman J. B., Cordell H. J., Prilchard L. E., Reed P. W., Gough S. C.L., Jenkins S. C., Palmer S. M., Balfour K. M., Rowe B., Farrall M., Barnctt A. H., Bain S. C., Todd J. A. A genome-wide search for human type I diabetes susceptibility genes. Nature 1994; 371: 130–136
- Todd J. A., Farrall M. Panning for gold: genome-wide scanning for linkage in type I diabetes. Hum. Mol. Genet. 1996; 5: 1443–1448
- Todd J. A., Bell J. I., McDevitt H. O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604
- Lucassen A. M., Screalon G. R., Julier C., Elliott T. J., Lathrop M., Bell J. I. Regulation of insulin gene expression by the IDDM associated, insulin locus haplolype. Hum. Mol. Genet. 1995; 4: 501–506
- Bell G. I., Horita S., Karam J. H. A polymorphic locus near the human insulin gene is associated with insulindependent diabetes mellitus. Diabetes 1984; 33: 176–183
- Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., DeGroot L. J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 1995; 80: 41–45
- Water-House P., Penninger J. M., Timms F., Wakeham A., Shahinian A., Lee K. P., Thompson C. B., Greisser H., Mak T. W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1996; 270: 985–988
- Chambers C. A., Krummel M. F., Boitcl B., Hurwitz A., Sullivan T. J., Fournier S., Cassell D., Brunner M., Allison J. P. The role of CTLA-4 in the regulation of T-cell responses. Immunol. Rev. 1996; 153: 27–46
- Nistico L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C., Bosi E., Larrad M. T.M., Rios M. S., Chow C. C., Cockram C. S., Jacobs K., Mijovic C., Bain S. C., Barnett A. M., Vandewalle C. L., Schit F., Gorus F. K., Belgian Diabetes Registry, Tosi R., Pozzilli P., Todd J. A. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 1996; 5: 1075–1080
- Kasuga A., Maruyama T., Ozawa Y., Takei I., Falorni A., Lernmark Á., Saruta T. Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes mellitus in Japanese. J. Autoimmunity 1996; 9: 105–111
- Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 1955; 19: 251
- Donner H., Rau H., Walfish P. G., Braun J., Siegmund T., Finke R., Herwig J., Usadel K. H., Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 1997; 82: 143–146
- Kotsa K., Watson P. F., Weetman A. P. A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin. Endocrinol. 1997; 46: 551–554
- Yanagawa T., Taniyama M., Enomoto S., Gomi K., Maruyama H., Ban Y., Saruta T. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7: 843–846
- Donner H., Braun J., Seidl C., Rau H., Finke R., Ventz M., Walfish P. G., Usadel K. H., Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metah. 1997; 82: 4130–4132
- Seidl C, Donner H., Fischer B., Usadel K. H., Kalt-Wasser J. P., Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998; 51: 62–66
- Marron M. P., Raffel L. J., Garchon H. J., Jacob C. O., Serranorios M., Larrad M. T.M., Teng W. P., Park Y., Zhang Z. X., Goldstein D. R., Tao Y. W., Beaurain G., Bach J. F., Huang H. S., Luo D. F., Zeidler A., Rotter J. I., Yang M. C.K., Modilevsky T., Maclaren N. K., She J. X. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 1997; 6: 1275–1282
- Van der Auera B., Vandewalle C. L., Schuit F. C., Winnock F., De Leeuw I. H., Van Imschoot S., Lambcrigts G., Gorus, F.K. and the Belgian diabetes registry. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. Exp. Immunol. 1997; 110: 98–103